Related Experiment Video
Updated: Aug 17, 2026

Use of Alu Element Containing Minigenes to Analyze Circular RNAs
Published on: March 10, 2020
Circular RNAs in atrial fibrillation: From bioinformatics analysis of circRNA-miRNA-mRNA network to serum expression
Zongqian Xue1, Jinbiao Zhu1, Juan Liu1
1Department of Cardiology, Aoyang Hospital Affiliated to Jiangsu University, Zhangjiagang, 215600, China.
Insights
Four specific circular RNAs (circRNAs) show increased expression in atrial fibrillation (AF) patients
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Genomics
Background:
- Atrial fibrillation (AF) is a prevalent arrhythmia with increasing incidence, significantly impacting patient survival and prognosis.
- Circular RNAs (circRNAs) are emerging as critical players in the diagnosis and treatment of AF.
Purpose of the Study:
- To identify differentially expressed circRNAs (DEcircRNAs) in the serum of AF patients using bioinformatics and chip analysis.
- To investigate the regulatory mechanisms of circRNAs in the pathogenesis of AF.
- To explore potential auxiliary diagnostic markers for AF.
Main Methods:
- Analysis of existing chip expression profile datasets from the Gene Expression Omnibus (GEO) database for AF.
- In vitro experiments and quantitative real-time PCR (qPCR) to verify selected circRNA expression levels.
- Bioinformatics prediction of signaling pathways regulated by DEcircRNAs.
Main Results:
- Identified four specific circRNAs with significantly increased expression in the serum of AF patients.
- These four DEcircRNAs show potential as auxiliary diagnostic markers for AF.
- Bioinformatics analysis predicted related signaling pathways involved in AF development.
Conclusions:
- The identified DEcircRNAs may serve as novel auxiliary diagnostic markers for atrial fibrillation.
- This study provides a new theoretical basis for understanding the molecular mechanisms underlying AF.
- Further research into circRNA regulatory networks can offer new therapeutic targets for AF.
Abstract:
Atrial fibrillation (AF) is a common arrhythmia in clinical practice, and its incidence is increasing year by year, which seriously affects the survival and prognosis of patients. In recent years, circRNAs has played an important role in the diagnosis and treatment of AF. The purpose of this study was to search for differentially expressed circRNAs(DEcircRNAs) in the serum of AF patients by analyzing the expression profile of existing chips, combining bioinformatics technology and in vitro experiments, and to explore the regulatory mechanism of circRNAs in the occurrence and development of AF. By using the AF datasets in the Gene expression omnibus (GEO) database, serum samples of patients with AF were collected, and the expression level of selected circRNAs was verified by qPCR. We found that the expression of four circRNAs was increased in the serum of patients with AF, suggesting that these four DEcircRNAs may be used as auxiliary diagnostic markers for AF. Bioinformatics predicts the related signaling pathways that differentially expressed genes may regulate in the occurrence and development of AF, providing a new theoretical basis for the molecular mechanism of the occurrence of atrial fibrillation and auxiliary diagnostic targets.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs

